Inossia AB Successfully Closes Oversubscribed Internal Rights Issue
Uppsala, Sweden – April 30, 2025 – Inossia AB, a pioneering company in the field of biomaterials for bone health, is pleased to announce the successful completion of its rights issue, which was oversubscribed by more than 100%. Initially targeting 5 million SEK, the rights issue closed at 10.3 million SEK, reflecting strong investor confidence […]
